182 related articles for article (PubMed ID: 30535439)
1. Intranasal erythropoietin ameliorates neurological function impairments and neural pathology in mice with chronic alcoholism by regulating autophagy‑related Nrf2 degradation.
Nie X; Wang W; Wang Q; Zhu D; Song H
Mol Med Rep; 2019 Feb; 19(2):1139-1149. PubMed ID: 30535439
[TBL] [Abstract][Full Text] [Related]
2. Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease.
Maurice T; Mustafa MH; Desrumaux C; Keller E; Naert G; de la C García-Barceló M; Rodríguez Cruz Y; Garcia Rodríguez JC
J Psychopharmacol; 2013 Nov; 27(11):1044-57. PubMed ID: 23813967
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor.
Xiong Y; Mahmood A; Qu C; Kazmi H; Zhang ZG; Noguchi CT; Schallert T; Chopp M
J Neurotrauma; 2010 Jan; 27(1):205-15. PubMed ID: 19715391
[TBL] [Abstract][Full Text] [Related]
4. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T
J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300
[TBL] [Abstract][Full Text] [Related]
5. Activity increase in EpoR and Epo expression by intranasal recombinant human erythropoietin (rhEpo) administration in ischemic hippocampi of adult rats.
Castañeda-Arellano R; Feria-Velasco AI; Rivera-Cervantes MC
Neurosci Lett; 2014 Nov; 583():16-20. PubMed ID: 25219375
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of erythropoietin against sevoflurane-induced neuronal apoptosis in primary rat cortical neurons involving the EPOR-Erk1/2-Nrf2/Bach1 signal pathway.
Zhang DX; Zhang LM; Zhao XC; Sun W
Biomed Pharmacother; 2017 Mar; 87():332-341. PubMed ID: 28064106
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin as a new therapeutic opportunity in brain inflammation and neurodegenerative diseases.
Merelli A; Czornyj L; Lazarowski A
Int J Neurosci; 2015; 125(11):793-7. PubMed ID: 25405533
[TBL] [Abstract][Full Text] [Related]
8. Different expression patterns of Ngb and EPOR in the cerebral cortex and hippocampus revealed distinctive therapeutic effects of intranasal delivery of Neuro-EPO for ischemic insults to the gerbil brain.
Gao Y; Mengana Y; Cruz YR; Muñoz A; Testé IS; García JD; Wu Y; Rodríguez JC; Zhang C
J Histochem Cytochem; 2011 Feb; 59(2):214-27. PubMed ID: 21339183
[TBL] [Abstract][Full Text] [Related]
9. The nasal route as a potential pathway for delivery of erythropoietin in the treatment of acute ischemic stroke in humans.
Garcia-Rodriguez JC; Sosa-Teste I
ScientificWorldJournal; 2009 Sep; 9():970-81. PubMed ID: 19768354
[TBL] [Abstract][Full Text] [Related]
10. Aqueous extract from You-Gui-Yin ameliorates cognitive impairment of chronic renal failure mice through targeting hippocampal CaMKIIα/CREB/BDNF and EPO/EPOR pathways.
Tang Q; Ke H; Wu C; Zeng J; Li Z; Liu Y; Feng S; Xue Q; Xu X
J Ethnopharmacol; 2019 Jul; 239():111925. PubMed ID: 31055001
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin.
Zakharova ET; Sokolov AV; Pavlichenko NN; Kostevich VA; Abdurasulova IN; Chechushkov AV; Voynova IV; Elizarova AY; Kolmakov NN; Bass MG; Semak IV; Budevich AI; Kozhin PM; Zenkov NK; Klimenko VM; Kirik OV; Korzhevskii DE; Menshchikova EB; Vasilyev VB
Biometals; 2018 Jun; 31(3):425-443. PubMed ID: 29748743
[TBL] [Abstract][Full Text] [Related]
12. Targeting erythropoietin for chronic neurodegenerative diseases.
Chong ZZ; Shang YC; Mu Y; Cui S; Yao Q; Maiese K
Expert Opin Ther Targets; 2013 Jun; 17(6):707-20. PubMed ID: 23510463
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin induces nuclear translocation of Nrf2 and heme oxygenase-1 expression in SH-SY5Y cells.
Genc K; Egrilmez MY; Genc S
Cell Biochem Funct; 2010 Apr; 28(3):197-201. PubMed ID: 20229611
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin rescues primary rat cortical neurons from pyroptosis and apoptosis via Erk1/2-Nrf2/Bach1 signal pathway.
Li R; Zhang LM; Sun WB
Brain Res Bull; 2017 Apr; 130():236-244. PubMed ID: 28189515
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin Rescues Memory Impairment in a Rat Model of Chronic Cerebral Hypoperfusion via the EPO-R/JAK2/STAT5/PI3K/Akt/GSK-3β Pathway.
Ma S; Chen J; Chen C; Wei N; Xu J; Yang G; Wang N; Meng Y; Ren J; Xu Z
Mol Neurobiol; 2018 Apr; 55(4):3290-3299. PubMed ID: 28488208
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin ameliorates diabetes-associated cognitive dysfunction in vitro and in vivo.
Wang M; Yan W; Liu Y; Hu H; Sun Q; Chen X; Zang W; Chen L
Sci Rep; 2017 Jun; 7(1):2801. PubMed ID: 28584284
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin-mediated protection of insect brain neurons involves JAK and STAT but not PI3K transduction pathways.
Miljus N; Heibeck S; Jarrar M; Micke M; Ostrowski D; Ehrenreich H; Heinrich R
Neuroscience; 2014 Jan; 258():218-27. PubMed ID: 24269933
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model.
Ruscher K; Freyer D; Karsch M; Isaev N; Megow D; Sawitzki B; Priller J; Dirnagl U; Meisel A
J Neurosci; 2002 Dec; 22(23):10291-301. PubMed ID: 12451129
[TBL] [Abstract][Full Text] [Related]
19. Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin.
Byts N; Samoylenko A; Fasshauer T; Ivanisevic M; Hennighausen L; Ehrenreich H; Sirén AL
Cell Death Differ; 2008 Apr; 15(4):783-92. PubMed ID: 18259195
[TBL] [Abstract][Full Text] [Related]
20. Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. Laboratory investigation.
Fletcher L; Kohli S; Sprague SM; Scranton RA; Lipton SA; Parra A; Jimenez DF; Digicaylioglu M
J Neurosurg; 2009 Jul; 111(1):164-70. PubMed ID: 19284235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]